About three weeks ago, I caught the end of a news report on the BBC. It went along the lines that any new vaccines, etc, (I presume antibodies are included) manufactured outside Germany but to be trialled in Germany are almost guaranteed to fail safety checks because the tests involved are so stringent. Anybody know if the Amgen tests are to be conducted in Germany, as most of PAB's trials have been to date. If so, wondering if this is the case for delays.
What's the root cause of PAB's poor SP performance?, page-11
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |